On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayAug 14, 2017 9:08 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Launches Cryptocurrency Education and Trading Subscription Service

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced the launch of its cryptocurrency education and trading subscription service on Chinesefn.com. The new subscription service will cover news and provide analysis regarding all aspects of the emerging digital currency world, including industry trends, price movement and sector related stocks. “Cryptocurrencies like bitcoin have become a global phenomenon,” Warren Wang, founder and CEO of CIIX, stated in the news release. “Since January 2015, the price of Bitcoin has increased 500% from $200 to $1,000 in January 2017, and just spiked to a record high over $4,000 as US-North Korea tensions…

Continue Reading

FridayAug 11, 2017 12:33 pm

NetworkNewsBreaks – Tecnoglass, Inc. (NASDAQ: TGLS) Posts Q2 Results, Lowers FY Guidance; Shares at New 52-Week Low

Shares of Tecnoglass (NASDAQ: TGLS) reached a new 52-week low after the company reported second-quarter results, lowered its full-year 2017 outlook, and announced a 12% increase in its quarterly dividend to $0.14 for Q3. The manufacturer of architectural glass, windows and aluminum products reported total revenues of $81.0 million, an increase of 1.5% over the prior-year period. Adjusted net loss for the quarter was $2.6 million, or $0.08 per diluted share, compared to $9.3 million, or $0.28 per share. Tecnoglass now expects full-year revenues in the range of $320 million-$330 million compared to previous guidance of $360 million-$390 million. More…

Continue Reading

FridayAug 11, 2017 9:58 am

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Soars on Private Placement, Canceled Deal with Kalani Investments

Coming off an earlier trading halt, shares of DryShips (NASDAQ: DRYS) are up 84% following news the company will sell its common shares to entities affiliated with its chairman and CEO, George Economou, for aggregate consideration of $100 million at a price of $2.75 per share. The board's  Audit Committee also approved a subsequent rights offering that would allow DryShips shareholders to purchase their pro rata portion of up to $100 million of the Company's common shares at a price of $2.75 per share. The Rights Offering will be backstopped in full by Sierra Investments Inc., an entity affiliated with…

Continue Reading

FridayAug 11, 2017 9:24 am

NetworkNewsBreaks – EnteroMedics, Inc. (NASDAQ: ETRM) Prices $20M Public Offering

EnteroMedics (NASDAQ:ETRM), a developer of minimally invasive medical devices for the treatment of obesity, metabolic diseases and other gastrointestinal disorders, this morning priced its underwritten public offering of 20,000 units at a price to the public of $1,000 per unit. The gross proceeds to EnteroMedics is expected to be $20 million. A total of 20,000 shares of preferred stock convertible into 8.7 million shares of common stock, and warrants to purchase 8.7 million shares of common stock will be issued in the offering. The closing of the offering is expected to take place on or about August 16, 2017. To…

Continue Reading

ThursdayAug 10, 2017 2:58 pm

NetworkNewsBreaks – Invictus MD Strategies Corp. (OTC: IVITF) (TSX-V: IMH) Provides Update on Harvesting

Invictus MD Strategies Corp. (OTC: IVITF) (TSX-V: IMH) today announced the completion of its wholly owned subsidiary’s first two harvests earlier this month. Both harvests exceeded expectations and two more harvests are expected the first week of September. Additionally, the company reported that the 27,800 sq. ft. production facility currently under construction is scheduled for completion by the end of January 2018. The additional space is projected to increase production by 800%. Dan Kriznic, Chairman & CEO, Invictus MD, commented, "Invictus MD is well capitalized for expansion with approximately $28.5 million in cash and is prepared for an exciting year of…

Continue Reading

ThursdayAug 10, 2017 9:53 am

NetworkNewsBreaks – Arcadia Biosciences, Inc. (NASDAQ: RKDA) and Bioceres’ Joint Venture Receives Completed Safety Review by FDA

Arcadia Biosciences (NASDAQ: RKDA) before the bell said its joint venture with Bioceres S.A., Verdeca, has received notification that the FDA has completed its full review of the company’s safety evaluation for HB4 soybeans. This permits Verdeca products derived from HB4 soybeans to be used commercially in human food and animal feed. Additionally, completion of the FDA’s review marks a key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The company has submitted an environmental safety data petition to the U.S. Department of Agriculture (USDA) which is currently under review. The USDA is expected to…

Continue Reading

ThursdayAug 10, 2017 9:49 am

NetworkNewsBreaks – Data and Safety Monitoring Board Recommends Completion of ARCA biopharma, Inc.’s (NASDAQ: ABIO) GENETIC-AF Trial

ARCA biopharma (NASDAQ: ABIO) this morning said the GENETIC-AF trial Data and Safety Monitoring Board (DSMB) has completed its pre-specified phase 2B interim analysis and has recommended completion of the study with no changes to the trial design. GENETIC-AF is a clinical trial evaluating Gencaro™ as a candidate for the treatment of atrial fibrillation (AF). The Gencaro development program has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). “The DSMB stated that there were no safety concerns and that the efficacy results met the prespecified criteria for continuing the Phase 2B trial to completion. We…

Continue Reading

ThursdayAug 10, 2017 9:32 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show. Bunka leveraged the platform to discuss Lexaria’s overall accomplishments in the past three months, as well as the company’s expectations for profitability moving forward. He notes that ongoing research and development programs could open both the NSAID and Nicotine markets to Lexaria, providing an opportunity to significantly increase corporate revenues and facilitate further expansion. “In the…

Continue Reading

WednesdayAug 09, 2017 12:40 pm

NetworkNewsBreaks – IPO Complete, China Internet Nationwide Financial Services, Inc. (NASDAQ: CIFS) Focuses on Providing Financial Solutions to Target Market in China

China Internet Nationwide Financial Services (NASDAQ: CIFS), on its second day as a NASDAQ-listed company, is trading at $11.93 on volume of just over 70,000. The provider of financial advisory services to the underserved small-to-medium sized enterprises in China yesterday ended its first day of trading up 23% at $12.30 per share. Boustead Securities, LLC served as the company’s lead underwriter and completed its IPO of 2,023,146 of CIFS’s ordinary shares priced at $10 per share for a total of $20,231,460 before underwriting discounts, commissions and offering expenses. "We are honored and humbled to become an official member of the…

Continue Reading

WednesdayAug 09, 2017 12:34 pm

NetworkNewsBreaks – Amyris, Inc. (NASDAQ: AMRS) Close $50M in Second Tranche Equity Financing; Shares Fall

Amyris (NASDAQ: AMRS) is trading at a new 52-week low of $2.54, down more than 8% after reporting the close of the second and final tranche of its previously announced financing. The second tranche of a private placement resulted in a total of $50 million, comprised of a $25-million investment from Koninklijke DSM N.V. and $25 million contributed by Vivo Capital. “We’ve delivered a very strong first half and are on track for our best year ever with more than doubling our product sales and continuing to build on our collaboration agreements while reducing our losses. As a result, later…

Continue Reading

Contact us: 212.418.1217